Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
Status:
Unknown status
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bevacizumab 1-2 weeks before vitrectomy is
effective in lowering the rate of early post-vitrectomy vitreous hemorrhage in diabetic
patients.